← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 31, 2020Last known activity
Oct 31, 2020
Defunct as of Dec 31, 2025
Timeline
2010s
- Jul 1, 2013
ElsaLys Biotech— Founded
2020s
- Dec 31, 2025
ElsaLys Biotech— Defunct
Drugs by trial phase (1 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Recent trials (2)
- NCT05047328Lead sponsorN/A—
- NCT04289103Lead sponsorPhase 3Oct 31, 2020
Details
- Founded
- Lyon, FR Jul 1, 2013
- Last known activity
- Oct 31, 2020